Related Experiment Video
Updated: Aug 6, 2026
08:38
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
A Point-of-Care Test to Measure Tacrolimus Directly from Unprocessed Whole Blood
Damon T Burrow1, David S Kinnamon1,2, Jacob T Heggestad1,2
1Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, North Carolina27708, United States.
Analytical Chemistry
|July 16, 2026
Summary
A new point-of-care test (POCT) provides rapid tacrolimus blood level results within 1 hour. This novel test aids in personalized immunosuppressant dosing for transplant patients, improving outcomes and reducing complications.
Area of Science:
- Immunology
- Pharmacology
- Biomedical Engineering
Background:
- Tacrolimus is a vital immunosuppressant for preventing organ transplant rejection.
- Therapeutic drug monitoring (TDM) is essential due to tacrolimus's narrow therapeutic window and variable patient response.
- Current TDM methods have limitations, including slow turnaround times and complex procedures, delaying critical dosing adjustments.
Purpose of the Study:
- To address the need for rapid, accessible tacrolimus monitoring.
- To introduce a novel point-of-care test (POCT) for tacrolimus quantification.
- To overcome logistical barriers in tacrolimus therapy management.
Main Methods:
- Development of the TAC-D4 POCT, a novel device for tacrolimus measurement.
- Direct measurement of tacrolimus levels from whole blood samples.
- Automated results available within 1 hour without complex sample preparation.
Main Results:
- The TAC-D4 POCT provides rapid (1-hour) tacrolimus level results.
- The test requires no sample preparation or expensive analyzers.
- The system is modular and can monitor other biomarkers like IL-6 and MMP-3.
Conclusions:
- The TAC-D4 POCT offers a significant advancement over traditional tacrolimus TDM methods.
- This rapid, bedside testing facilitates personalized dosing and improves patient management.
- The technology has the potential to enhance patient adherence, clinical outcomes, and reduce treatment-related toxicities.
